NM_000516.7:c.585+6C>T

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_000516.7(GNAS):​c.585+6C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000192 in 1,611,878 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000085 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00020 ( 0 hom. )

Consequence

GNAS
NM_000516.7 splice_region, intron

Scores

2
Splicing: ADA: 0.0002300
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2B:1

Conservation

PhyloP100: -0.530

Publications

0 publications found
Variant links:
Genes affected
GNAS (HGNC:4392): (GNAS complex locus) This locus has a highly complex imprinted expression pattern. It gives rise to maternally, paternally, and biallelically expressed transcripts that are derived from four alternative promoters and 5' exons. Some transcripts contain a differentially methylated region (DMR) at their 5' exons, and this DMR is commonly found in imprinted genes and correlates with transcript expression. An antisense transcript is produced from an overlapping locus on the opposite strand. One of the transcripts produced from this locus, and the antisense transcript, are paternally expressed noncoding RNAs, and may regulate imprinting in this region. In addition, one of the transcripts contains a second overlapping ORF, which encodes a structurally unrelated protein - Alex. Alternative splicing of downstream exons is also observed, which results in different forms of the stimulatory G-protein alpha subunit, a key element of the classical signal transduction pathway linking receptor-ligand interactions with the activation of adenylyl cyclase and a variety of cellular reponses. Multiple transcript variants encoding different isoforms have been found for this gene. Mutations in this gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progressive osseus heteroplasia, polyostotic fibrous dysplasia of bone, and some pituitary tumors. [provided by RefSeq, Aug 2012]
GNAS Gene-Disease associations (from GenCC):
  • McCune-Albright syndrome
    Inheritance: AD, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • progressive osseous heteroplasia
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE, NO_KNOWN Submitted by: G2P, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • pseudohypoparathyroidism type 1B
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
  • pseudohypoparathyroidism type 1C
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
  • pseudopseudohypoparathyroidism
    Inheritance: AD, Mitochondrial Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • pseudohypoparathyroidism type 1A
    Inheritance: Mitochondrial, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BS2
High AC in GnomAd4 at 13 AD,Mitochondrial,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GNASNM_080425.4 linkc.2514+6C>T splice_region_variant, intron_variant Intron 7 of 12 ENST00000371100.9 NP_536350.2
GNASNM_000516.7 linkc.585+6C>T splice_region_variant, intron_variant Intron 7 of 12 ENST00000371085.8 NP_000507.1
GNASNM_016592.5 linkc.*491+6C>T splice_region_variant, intron_variant Intron 7 of 12 ENST00000371075.7 NP_057676.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GNASENST00000371100.9 linkc.2514+6C>T splice_region_variant, intron_variant Intron 7 of 12 5 NM_080425.4 ENSP00000360141.3
GNASENST00000371085.8 linkc.585+6C>T splice_region_variant, intron_variant Intron 7 of 12 1 NM_000516.7 ENSP00000360126.3
GNASENST00000371075.7 linkc.*491+6C>T splice_region_variant, intron_variant Intron 7 of 12 1 NM_016592.5 ENSP00000360115.3
GNASENST00000676826.2 linkc.2517+6C>T splice_region_variant, intron_variant Intron 7 of 12 ENSP00000504675.2
GNASENST00000371102.8 linkc.2472+6C>T splice_region_variant, intron_variant Intron 6 of 11 5 ENSP00000360143.4
GNASENST00000354359.12 linkc.588+6C>T splice_region_variant, intron_variant Intron 7 of 12 1 ENSP00000346328.7
GNASENST00000371095.7 linkc.543+6C>T splice_region_variant, intron_variant Intron 6 of 11 1 ENSP00000360136.3
GNASENST00000470512.6 linkc.411+6C>T splice_region_variant, intron_variant Intron 7 of 12 5 ENSP00000499552.2
GNASENST00000480232.6 linkc.411+6C>T splice_region_variant, intron_variant Intron 8 of 13 5 ENSP00000499545.2
GNASENST00000663479.2 linkc.411+6C>T splice_region_variant, intron_variant Intron 7 of 12 ENSP00000499353.2
GNASENST00000462499.6 linkc.366+6C>T splice_region_variant, intron_variant Intron 6 of 11 2 ENSP00000499758.2
GNASENST00000467227.6 linkc.366+6C>T splice_region_variant, intron_variant Intron 7 of 12 3 ENSP00000499681.2
GNASENST00000478585.6 linkc.366+6C>T splice_region_variant, intron_variant Intron 6 of 11 2 ENSP00000499762.2
GNASENST00000481039.6 linkc.366+6C>T splice_region_variant, intron_variant Intron 6 of 11 5 ENSP00000499767.2
GNASENST00000485673.6 linkc.366+6C>T splice_region_variant, intron_variant Intron 6 of 11 5 ENSP00000499334.2
GNASENST00000488546.6 linkc.366+6C>T splice_region_variant, intron_variant Intron 6 of 11 5 ENSP00000499332.2
GNASENST00000492907.6 linkc.366+6C>T splice_region_variant, intron_variant Intron 6 of 11 3 ENSP00000499443.2
GNASENST00000453292.7 linkc.*446+6C>T splice_region_variant, intron_variant Intron 6 of 11 5 ENSP00000392000.2

Frequencies

GnomAD3 genomes
AF:
0.0000854
AC:
13
AN:
152210
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000636
AC:
16
AN:
251472
AF XY:
0.0000515
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000105
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000203
AC:
297
AN:
1459668
Hom.:
0
Cov.:
31
AF XY:
0.000204
AC XY:
148
AN XY:
726280
show subpopulations
African (AFR)
AF:
0.0000598
AC:
2
AN:
33434
American (AMR)
AF:
0.00
AC:
0
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26120
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86232
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.000250
AC:
278
AN:
1109964
Other (OTH)
AF:
0.000282
AC:
17
AN:
60328
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
12
25
37
50
62
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000854
AC:
13
AN:
152210
Hom.:
1
Cov.:
32
AF XY:
0.0000941
AC XY:
7
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41454
American (AMR)
AF:
0.00
AC:
0
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5202
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000176
AC:
12
AN:
68032
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000113
Hom.:
0
Bravo
AF:
0.000140
EpiCase
AF:
0.000164
EpiControl
AF:
0.000178

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 21, 2017
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
Jan 11, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change falls in intron 7 of the GNAS gene. It does not directly change the encoded amino acid sequence of the GNAS protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs373084986, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with GNAS-related conditions. ClinVar contains an entry for this variant (Variation ID: 435344). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

GNAS-related disorder Benign:1
Nov 03, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
11
DANN
Benign
0.51
PhyloP100
-0.53
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00023
dbscSNV1_RF
Benign
0.062
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs373084986; hg19: chr20-57484277; COSMIC: COSV105846548; API